Spectrum gets FDA plant approval; Hovione and Solvias pair up on co-crystals; Public Citizen wants compounders inspected;

> Spectrum Pharmaceuticals' new manufacturing site has received FDA approval for the production of Fusilev injection for use in advanced metastatic colorectal cancer patients. Item

> Hovione has buddied up with Solvias to combine formulation capabilities and crystal design for manufacturing pharmaceutical co-crystals. Release

> The USP will delay new elemental impurities standards to get them synced up with those in ICH Q3D. Item

> Watchdog group Public Citizen has requested that the FDA reinspect more than a dozen specialty pharmacies with prior records of violations in light of the lethal meningitis outbreak tied to drugs manufactured by New England Compounding Center. Story

And Finally... Johnson & Johnson ($JNJ) says it is making its HIV drug Prezista available to generics makers in Africa and developing countries. Story

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.